reform
Ex-FDA Leaders Launch Canal Row Advisors, Offer Insights on Agency’s Challenges and Direction
Canal Row Advisors; FDA leadership; regulatory consulting; Michael Rogers; Hilary Marston; life sciences; regulatory strategy; public health; FDA reform; innovation policy